Oncotelic Therapeutics Inc. (OTLC) OTC MARKETS

$0.04 - (-)

Market Cap: $15.71M

As of 04/22/24 12:00 AM EDT. Market closed.

(OTLC)

Oncotelic Therapeutics Inc. (OTLC)
OTC MARKETS

$0.04
- (-)

Market Cap: $15.71M

As of 04/22/24 12:00 AM EDT. Market closed.

Add to Portfolio
COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
PRICE CHART FOR ONCOTELIC THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
$0.04
Days Range
$0.04 - $0.04
52 week range
$0.01 - $0.05
Volume
3,500
Avg. Volume (30 days)
79,300
Market Cap
$15.71M
Dividend Yield
-
P/E
(1.37)
Shares Outstanding
398,664,555
Open
-
Previous Close
$0.04
Days Range
$0.04 - $0.04
52 week range
$0.01 - $0.05
Volume
3,500
Avg. Volume (30 days)
79,300
Market Cap
$15.71M
Dividend Yield
-
P/E
(1.37)
Shares Outstanding
398,664,555
FINANCIAL STATEMENTS FOR ONCOTELIC THERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ONCOTELIC THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Trieu VuongCHAIRMAN AND CEOJun 28, 2023 Buy$0.0375,0001,95091,619,217Jun 30, 2023, 09:25 AM
Trieu VuongCHAIRMAN AND CEOJun 29, 2023 Buy$0.02425,0008,92592,044,217Jun 30, 2023, 09:25 AM
Trieu VuongCHAIRMAN AND CEOJun 16, 2023 Buy$0.03100,0002,60091,544,217Jun 20, 2023, 12:00 PM
Trieu VuongCHAIRMAN AND CEOJun 14, 2023 Buy$0.03400,00013,04091,444,217Jun 16, 2023, 12:00 PM
Trieu VuongCHAIRMAN AND CEOMay 26, 2023 Buy$0.03126,8884,32791,044,217May 31, 2023, 09:39 AM
Trieu VuongCHAIRMAN AND CEOMay 02, 2023 Buy$0.05100,0004,50090,917,329May 02, 2023, 05:00 PM
Trieu VuongCHAIRMAN AND CEODec 06, 2022 Buy$0.05120,0006,00090,558,021Dec 07, 2022, 08:00 AM
Trieu VuongCHAIRMAN AND CEONov 22, 2022 Buy$0.0870,0005,60090,438,021Nov 25, 2022, 09:00 AM
Trieu VuongCHAIRMAN AND CEOSep 26, 2022 Buy$0.0720,0001,36090,368,021Sep 28, 2022, 09:15 AM
Trieu VuongCHAIRMAN AND CEOAug 25, 2022 Buy$0.0880,0006,56090,348,021Aug 29, 2022, 09:15 AM
Shah Amit B.CHIEF FINANCIAL OFFICERNov 23, 2020 Buy$0.1920,0883,81751,780Nov 24, 2020, 05:30 PM
Shah Amit B.CHIEF FINANCIAL OFFICERNov 20, 2020 Buy$0.1931,6926,18031,692Nov 24, 2020, 05:30 PM
Shah Amit B.CHIEF FINANCIAL OFFICERNov 24, 2020 Buy$0.198,2201,56260,000Nov 24, 2020, 05:30 PM
Park ChulhoCHIEF TECHNOLOGY OFFICERNov 19, 2020 Buy$0.1822,1734,0982,833,992Nov 23, 2020, 03:01 PM
Trieu VuongCHIEF EXECUTIVE OFFICERNov 19, 2020 Buy$0.1950,5009,59515,812,308Nov 23, 2020, 03:01 PM
Trieu VuongCHIEF EXECUTIVE OFFICERMar 26, 2020 Buy$0.123,00036015,761,808Mar 27, 2020, 05:49 PM
Reynolds Donald RogersDirectorDec 16, 2016 Buy$0.3530,00010,42330,000Dec 20, 2016, 04:15 PM
LANGECKER PETERChief Executive OfficerJun 28, 2013 Buy$2.753,0008,2505,000Jul 01, 2013, 12:31 PM
LANGECKER PETERChief Executive OfficerJun 25, 2013 Buy$2.792,0005,5722,000Jun 26, 2013, 06:06 PM
Wood Alastair JJDirectorJan 02, 2011 Option Exercise$0.2325,0005,750115,000Jan 04, 2011, 09:50 PM
Schwieterman William DDirectorJan 02, 2011 Option Exercise$0.2325,0005,750179,208Jan 04, 2011, 09:50 PM
SHIEBLER WILLIAM NDirectorJan 02, 2011 Option Exercise$0.2325,0005,750236,002Jan 04, 2011, 09:50 PM
KESSEL MARKDirectorJan 02, 2011 Option Exercise$0.2325,0005,750115,000Jan 04, 2011, 09:49 PM
HOWSON TAMAR DDirectorJan 02, 2011 Option Exercise$0.2325,0005,75075,000Jan 04, 2011, 09:49 PM
FICKLING ROY HDirectorJan 02, 2011 Option Exercise$0.2325,0005,750202,846Jan 04, 2011, 09:48 PM
HOWSON TAMAR DDirectorJul 01, 2010 Option Exercise$0.3825,0009,50350,000Sep 15, 2010, 06:40 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Trieu VuongCHAIRMAN AND CEO06/28/20231,950
Trieu VuongCHAIRMAN AND CEO06/29/20238,925
Trieu VuongCHAIRMAN AND CEO06/16/20232,600
Trieu VuongCHAIRMAN AND CEO06/14/202313,040
Trieu VuongCHAIRMAN AND CEO05/26/20234,327
Trieu VuongCHAIRMAN AND CEO05/02/20234,500
Trieu VuongCHAIRMAN AND CEO12/06/20226,000
Trieu VuongCHAIRMAN AND CEO11/22/20225,600
Trieu VuongCHAIRMAN AND CEO09/26/20221,360
Trieu VuongCHAIRMAN AND CEO08/25/20226,560
Shah Amit B.CHIEF FINANCIAL OFFICER11/23/20203,817
Shah Amit B.CHIEF FINANCIAL OFFICER11/20/20206,180
Shah Amit B.CHIEF FINANCIAL OFFICER11/24/20201,562
Park ChulhoCHIEF TECHNOLOGY OFFICER11/19/20204,098
Trieu VuongCHIEF EXECUTIVE OFFICER11/19/20209,595
Trieu VuongCHIEF EXECUTIVE OFFICER03/26/2020360
Reynolds Donald RogersDirector12/16/201610,423
LANGECKER PETERChief Executive Officer06/28/20138,250
LANGECKER PETERChief Executive Officer06/25/20135,572
Wood Alastair JJDirector01/02/20115,750
Schwieterman William DDirector01/02/20115,750
SHIEBLER WILLIAM NDirector01/02/20115,750
KESSEL MARKDirector01/02/20115,750
HOWSON TAMAR DDirector01/02/20115,750
FICKLING ROY HDirector01/02/20115,750
HOWSON TAMAR DDirector07/01/20109,503
Load More Insider Transactions
BUYBACK ANNOUNCEMENT(S) FOR ONCOTELIC THERAPEUTICS INC
LOADING...